Join to View Full Profile
550 1st AveNew York, NY 10016
Phone+1 212-263-5506
Are you Dr. Probst?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stephan Probst, MD is a nuclear medicine physician in New York, New York. He is currently licensed to practice medicine in New York.
Education & Training
McGill University Faculty of MedicineClass of 2004, MD
Certifications & Licensure
NY State Medical License 2009 - 2011
Clinical Trials
- 68Ga-PSMA PET/CT in Prostate Cancer Start of enrollment: 2017 Jul 01
- Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer Start of enrollment: 2017 Jul 01
- Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy Start of enrollment: 2018 Mar 22
- Join now to see all
Publications & Presentations
PubMed
- Variants of physiological FDG vascular activity on digital PET.Phillip Yin, Peter G Maliha, Anwar Ebrahim, Noah Ben-Ezra, Laurent Azoulay
Nuclear Medicine Communications. 2025-03-01 - 5 citationsIntrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study.Frédéric Pouliot, Fred Saad, Etienne Rousseau, Patrick O Richard, Atefeh Zamanian
Journal of Nuclear Medicine. 2024-11-01 - A phase 2, single-arm trial evaluating 131 I-PSMA-1095 targeted radioligand therapy for metastatic castration-resistant prostate cancer.Richard F Liu, Cristiano Ferrario, Parvaneh Fallah, April A N Rose, Soumaya Labidi
Nuclear Medicine Communications. 2024-08-01
